ArticleFrontiers in oncology2026

AAT score based on pretreatment indicators predicts outcomes in unresectable HCC patients treated with TACE, Sintilimab, and Bevacizumab.

Wanying Qin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.